Clinical trials: Juvenile Myoclonic Epilepsy, open to volunteers
Juvenile Myoclonic Epilepsy
Biology of Juvenile Myoclonic Epilepsy
The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America.
- Trial name
- BIOJUME (NCT03400371)
- Testing
- Blood draw, Existing samples
- Where
- 15 sites in United States, Canada and 7 more
- Volunteers
- 1,000 people
- Sponsor
- King's College London
Juvenile Myoclonic Epilepsy
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy
This study is being conducted to evaluate the safety and efficacy of JZP926 capsule in participants with Juvenile Myoclonic Epilepsy (JME).
- Trial name
- NCT07723963
- Testing
- JZP926 capsule
- Where
- 23 sites in United States
- Volunteers
- 260 people
- Sponsor
- Jazz Pharmaceuticals